Clinical Trial Update: GSK2190915 Safety and Pharmacokinetic Study in Healthy Japanese Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of the investigational compound GSK2190915 in healthy Japanese subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2190915

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED